TECTONIC THERAPEUTIC, INC. Depreciation and Amortization Expense
TECTONIC THERAPEUTIC, INC. (TECX) reported Depreciation and Amortization Expense of $584.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2020-08-06
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2020-06-30 was $301.00K, a 50.50% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2020-03-31 was $283.00K, a 48.95% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2019-12-31 was $245.00K, a 33.15% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2019-09-30 was $215.00K, a 65.38% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for fiscal 2019 was $850.00K, a 123.68% increase from fiscal 2018.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for fiscal 2018 was $380.00K, a 744.44% increase from fiscal 2017.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization, nonproduction for fiscal 2017 was $45.00K.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|
| 2020-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $584.00K 10-Q · filed 2020-08-06 | $829.00K derived: sum of 3 quarters · filed 2020-08-06 | $1.04M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $283.00K 10-Q · filed 2020-05-07 | $528.00K derived: sum of 2 quarters · filed 2020-05-07 | $743.00K derived: sum of 3 quarters · filed 2020-05-07 | $943.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $460.00K derived: sum of 2 quarters · filed 2020-03-16 | $660.00K derived: sum of 3 quarters · filed 2020-03-16 | $850.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $215.00K 10-Q · filed 2019-11-07 | $415.00K derived: sum of 2 quarters · filed 2019-11-07 | $605.00K 10-Q · filed 2019-11-07 | $789.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-08 | $390.00K 10-Q · filed 2020-08-06 | $574.00K derived: sum of 3 quarters · filed 2020-05-07 | $704.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-03-31 | $190.00K 10-Q · filed 2020-05-07 | $374.00K derived: sum of 2 quarters · filed 2020-05-07 | $504.00K derived: sum of 3 quarters · filed 2020-05-07 | $549.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $314.00K derived: sum of 2 quarters · filed 2020-03-16 | $359.00K derived: sum of 3 quarters · filed 2020-03-16 | $380.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $130.00K 10-Q · filed 2019-11-07 | $175.00K derived: sum of 2 quarters · filed 2019-08-08 | $196.00K 10-Q · filed 2019-11-07 | $213.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $45.00K 10-Q · filed 2019-08-08 | $66.00K 10-Q · filed 2019-08-08 | $83.00K derived: sum of 3 quarters · filed 2019-08-08 | $96.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $21.00K 10-Q · filed 2019-05-13 | $38.00K derived: sum of 2 quarters · filed 2019-05-13 | $51.00K derived: sum of 3 quarters · filed 2019-05-13 | $64.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $30.00K derived: sum of 2 quarters · filed 2019-03-25 | $43.00K derived: sum of 3 quarters · filed 2019-03-25 | $45.00K 10-K · filed 2019-03-25 |
| 2017-09-30 | $13.00K 10-Q · filed 2018-11-13 | $26.00K derived: sum of 2 quarters · filed 2018-11-13 | $28.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $13.00K 10-Q · filed 2018-08-09 | $15.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |